Publication:
Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE-I Study

dc.contributor.authorTÜRK M.
dc.contributor.authorYücel M. B.
dc.contributor.authorYILMAZ İ.
dc.contributor.authorErtaş R.
dc.contributor.authorŞAHİNER Ü. M.
dc.contributor.authorDemir S.
dc.contributor.authorGelincik A.
dc.contributor.authorÜnal D.
dc.contributor.authorÇelik Kamacı Ş.
dc.contributor.authorHörmet İğde M.
dc.contributor.authoret al.
dc.date.accessioned2026-01-28T21:37:00Z
dc.date.issued2026-01-01
dc.description.abstractBackground: Histamine plays a central role in CSU pathogenesis and may contribute to extracutaneous symptoms such as dysmenorrhea, but this relationship has not been fully examined. Methods: In this prospective, cross-sectional multicenter study, 425 female CSU patients and 370 age-matched controls were recruited from 19 UCARE centers in Türkiye. Dysmenorrhea prevalence and severity were assessed using a numerical scale and symptom scores. Histamine skin prick testing (SPT) was performed to evaluate histamine clearance capacity. Associations between dysmenorrhea, CSU phenotype, antihistamine use, and SPT kinetics were analyzed. Results: The prevalence and severity of dysmenorrhea were comparable between CSU patients and controls (81.6% vs. 79.5%, p = 0.244). However, 95/418 (22.7%) of CSU patients reported increased menstrual pain following CSU onset, and 20/95 (21.1%) of these reported partial relief with antihistamines. CSU patients with worsened dysmenorrhea exhibited significantly shorter histamine SPT positivity durations than those without symptom change (35 vs. 45 min; p = 0.015). No correlation was observed between dysmenorrhea severity and total IgE, anti-TPO levels, or urticaria control/activity scores. A moderate negative correlation was found between UAS7 and elapsed time to histamine SPT negativity (r = −0.389, p < 0.001). Conclusions: Although overall prevalence and severity of dysmenorrhea were similar in CSU patients and healthy controls, about one in five patients with CSU experienced worsening menstrual pain after disease onset, and only a subset of these patients reported partial improvement with antihistamines. A distinct CSU subgroup with heightened menstrual pain may be characterized by altered histamine dynamics. Whether these patients may benefit from more intensive antihistamine treatment remains uncertain and requires confirmation in future studies; further studies should explore neuroimmune and hormonal mechanisms underlying this overlap.
dc.identifier.citationTÜRK M., Yücel M. B., YILMAZ İ., Ertaş R., ŞAHİNER Ü. M., Demir S., Gelincik A., Ünal D., Çelik Kamacı Ş., Hörmet İğde M., et al., "Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE-I Study", International Journal of Dermatology, 2026
dc.identifier.doi10.1111/ijd.70252
dc.identifier.issn0011-9059
dc.identifier.pubmed41474111
dc.identifier.scopus105026347933
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105026347933&origin=inward
dc.identifier.urihttps://hdl.handle.net/20.500.12645/41648
dc.identifier.wosWOS:001651683500001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectDermatoloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectDermatology
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (Med)
dc.subjectKlinik Tıp
dc.subjectClinical Medicine (Med)
dc.subjectClinical Medicine
dc.subjectchronic spontaneous urticaria
dc.subjectdysmenorrhea
dc.subjecthistamine
dc.subjectskin prick test
dc.titleDysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE-I Study
dc.typearticle
dspace.entity.typePublication
local.avesis.id687badb1-0c2b-42ad-97bc-6c7dad91c1ef

Files